Filing Details
- Accession Number:
- 0001209191-21-046026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-08 18:13:38
- Reporting Period:
- 2021-07-06
- Accepted Time:
- 2021-07-08 18:13:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576885 | Acumen Pharmaceuticals Inc. | ABOS | Biological Products, (No Disgnostic Substances) (2836) | 364108129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1869596 | B Nathan Fountain | C/O Acumen Pharmaceuticals, Inc. 427 Park Street Charlottesville VA 22902 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-07-06 | 6,250 | $16.00 | 6,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
